TETRAHYDROOXEPINOPYRIDINE COMPOUND

[Problem] To provide a compound which has a positive allosteric modulating effect (PAM effect) for an ±7 nicotinic acetylcholine receptor (±7 nACh receptor). [Solution] The inventors have achieved the present invention by making studies on PAM effects for an ±7 nACh receptor and confirming that a te...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SATO, RYO, KUNIKAWA, SHIGEKI, KOGANEMARU, YOHEI, KAMIKAWA, AKIO, MIYAMOTO, SATOSHI, AOKI, SATOSHI, KOIZUMI, YUKA, TAMAKI, KEISUKE, SHISHIKURA, JUNICHI, OGIYAMA, TAKASHI, KAWAKAMI, SHIMPEI, KAKIMOTO, SHUICHIROU, YAMADA, HIROSHI, NAGASHIMA, SHINYA, YONEZAWA, KOICHI
Format:	Patent
Sprache:	eng ; pol
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[Problem] To provide a compound which has a positive allosteric modulating effect (PAM effect) for an ±7 nicotinic acetylcholine receptor (±7 nACh receptor). [Solution] The inventors have achieved the present invention by making studies on PAM effects for an ±7 nACh receptor and confirming that a tetrahydrooxepinopyridine compound has a PAM effect for an ±7 nACh receptor. A tetrahydrooxepinopyridine compound according to the present invention has a PAM effect for an ±7 nACh receptor, and is promising as a prophylactic or therapeutic agent for dementia, cognitive impairment, schizophrenia, Alzheimer's disease, CIAS, negative symptoms of schizophrenia, inflammatory diseases or pain.